U.S. Neurosurgical Holdings, Inc.
USNU
$0.83
-$0.005-0.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 103.29% | 156.29% | 80.58% | 266.15% | 25.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 103.29% | 156.29% | 80.58% | 266.15% | 25.91% |
| Operating Income | -103.29% | -156.29% | -80.58% | -266.15% | -25.91% |
| Income Before Tax | -3,546.43% | -93.33% | 14.87% | -274.02% | -104.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3,546.43% | -93.33% | 14.87% | -145.67% | -104.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -31.11% |
| Net Income | -599.32% | -128.35% | -0.23% | -188.89% | -128.91% |
| EBIT | -103.29% | -156.29% | -80.58% | -266.15% | -25.91% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -303.70% | -6.21% | 41.27% | -89.86% | -117.09% |
| Normalized Basic EPS | -169.31% | -18.89% | 34.20% | -223.38% | -116.08% |
| EPS Diluted | -303.70% | -6.21% | 41.27% | -89.86% | -117.09% |
| Normalized Diluted EPS | -169.31% | -18.89% | 34.20% | -223.38% | -116.08% |
| Average Basic Shares Outstanding | 74.05% | 115.49% | 70.86% | 51.73% | 68.45% |
| Average Diluted Shares Outstanding | 74.05% | 115.49% | 70.86% | 51.73% | 68.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |